Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Fibrinogen γ′ increases the sensitivity to activated protein C in normal and factor V Leiden plasma

Farida Omarova, Shirley Uitte de Willige, Paolo Simioni, Robert A. S. Ariëns, Rogier M. Bertina, Jan Rosing, Elisabetta Castoldi

Blood (2014) 124 (9): 1531–1538.

https://doi.org/10.1182/blood-2014-02-554055

Published: 2014

Journal Articles

The Effect of Aquaporin 2 Gene Variations on Plasma Levels of von Willebrand Factor and Factor VIII and on the Risk of Venous Thrombosis.

Anne Yael Nossent, MSc, Johanne H. Ellenbroek, Bsc, Marijke Frolich, PhD, Frits R. Rosendaal, Md PhD, Rogier M. Bertina, PhD, Nine V.A.M. Knoers, Md PhD, Jeroen C.J. Eikenboom, Md PhD

Blood (2007) 110 (11): 1749.

https://doi.org/10.1182/blood.V110.11.1749.1749

Published: 2007

Journal Articles

Polymorphism 10034C>T Is Located in a Functional Cleavage Stimulation Factor (CstF) Binding Site of the Fibrinogen Gamma Gene and Influences the γ′/γA mRNA Ratio.

Shirley Uitte de Willige, MSc, Inge M. Rietveld, Marieke C.H. de Visser, PhD, Hans L. Vos, PhD, Rogier M. Bertina, PhD

Blood (2006) 108 (11): 543.

https://doi.org/10.1182/blood.V108.11.543.543

Published: 2006

Journal Articles

Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen γ′ levels

Shirley Uitte de Willige, Marieke C. H. de Visser, Jeanine J. Houwing-Duistermaat, Frits R. Rosendaal, Hans L. Vos, Rogier M. Bertina

Blood (2005) 106 (13): 4176–4183.

https://doi.org/10.1182/blood-2005-05-2180

Published: 2005

Journal Articles

Microparticle-Associated Tissue Factor Activity: A Link between Cancer and Thrombosis?.

Margot E.T. Tesselaar, MD, Fred P.H.T.M. Romijn, Irma K. van der Linden, Frans Prins, Rogier M. Bertina, PhD, Susanne Osanto, PhD

Blood (2005) 106 (11): 260.

https://doi.org/10.1182/blood.V106.11.260.260

Published: 2005

Journal Articles

The Marburg I polymorphism of factor VII-activating protease is not associated with venous thrombosis

Rick van Minkelen, Marieke C. H. de Visser, Hans L. Vos, Rogier M. Bertina, Frits R. Rosendaal

Blood (2005) 105 (12): 4898–4899.

https://doi.org/10.1182/blood-2005-02-0576

Published: 2005

Journal Articles

Is the prothrombin 19911A>G polymorphism a functional noncoding variant?

Haidy H. A. G. M. van der Putten, Rogier M. Bertina, Hans L. Vos

Blood (2005) 105 (7): 2995–2996.

https://doi.org/10.1182/blood-2004-10-4154

Published: 2005

Journal Articles

Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis

Anders Dahm, Astrid van Hylckama Vlieg, Bjorn Bendz, Frits Rosendaal, Rogier M. Bertina, Per Morten Sandset

Blood (2003) 101 (11): 4387–4392.

https://doi.org/10.1182/blood-2002-10-3188

Published: 2003

Journal Articles

A novel, possibly functional, single nucleotide polymorphism in the coding region of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levels

Geert-Jan Brouwers, Hans L. Vos, Frank W. G. Leebeek, Saskia Bulk, Mark Schneider, Michael Boffa, Marlys Koschinsky, Nico H. van Tilburg, Michael E. Nesheim, Rogier M. Bertina, Encarnación B. Gómez Garcı́a

Blood (2001) 98 (6): 1992–1993.

https://doi.org/10.1182/blood.V98.6.1992

Published: 2001

Journal Articles

High levels of factor IX increase the risk of venous thrombosis

Astrid van Hylckama Vlieg, Irma K. van der Linden, Rogier M. Bertina, Frits R. Rosendaal

Blood (2000) 95 (12): 3678–3682.

https://doi.org/10.1182/blood.V95.12.3678

Published: 2000

Journal Articles

Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis

Nico H. van Tilburg, Frits R. Rosendaal, Rogier M. Bertina

Blood (2000) 95 (9): 2855–2859.

https://doi.org/10.1182/blood.V95.9.2855.009k02_2855_2859

Published: 2000

Journal Articles

A Reduced Sensitivity for Activated Protein C in the Absence of Factor V Leiden Increases the Risk of Venous Thrombosis

Marieke C.H. de Visser, Frits R. Rosendaal, Rogier M. Bertina

Blood (1999) 93 (4): 1271–1276.

https://doi.org/10.1182/blood.V93.4.1271

Published: 1999

Journal Articles

An In Vitro Analysis of the Combination of Hemophilia A and Factor V LEIDEN

Cornelis van ‘t Veer, Neal J. Golden, Michael Kalafatis, Paolo Simioni, Rogier M. Bertina, Kenneth G. Mann

Blood (1997) 90 (8): 3067–3072.

https://doi.org/10.1182/blood.V90.8.3067

Published: 1997

NARROW

Fibrinogen γ′ increases the sensitivity to activated protein C in normal and factor V Leiden plasma

The Effect of Aquaporin 2 Gene Variations on Plasma Levels of von Willebrand Factor and Factor VIII and on the Risk of Venous Thrombosis.

Polymorphism 10034C>T Is Located in a Functional Cleavage Stimulation Factor (CstF) Binding Site of the Fibrinogen Gamma Gene and Influences the γ′/γA mRNA Ratio.

Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen γ′ levels

Microparticle-Associated Tissue Factor Activity: A Link between Cancer and Thrombosis?.

The Marburg I polymorphism of factor VII-activating protease is not associated with venous thrombosis

Is the prothrombin 19911A>G polymorphism a functional noncoding variant?

Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis

A novel, possibly functional, single nucleotide polymorphism in the coding region of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levels

High levels of factor IX increase the risk of venous thrombosis

Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis

A Reduced Sensitivity for Activated Protein C in the Absence of Factor V Leiden Increases the Risk of Venous Thrombosis

An In Vitro Analysis of the Combination of Hemophilia A and Factor V LEIDEN

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only